Triclinium was founded in February 2000 by Managing Director Victor Strugo, who entered the pharmaceutical industry from academia in 1982. In a career that spans multinational Pharma, CROs and academic trial sites, he has been involved in over 400 Phase I to III clinical trials. He is directly responsible for marketing and business development.

Barbara Theron joined Triclinium in May 2001 with a Phase I Unit background and a wealth of experience in clinical research, registration, sales and marketing in pharmaceuticals and vaccines. Barbara is a Director and heads up Triclinium’s clinical projects group, comprising Project Managers, CRAs and CTAs.

Before joining Triclinium as Financial Director in 2003, Ronald van der Linde held the same position in a large industrial chemical company. He has been a board member of over 12 companies.

Marian Butt joined Triclinium in June 2000, from a clinical research position at Rhône–Poulenc Rorer, preceded by a banking background. She has recently been appointed a Director and is in charge of Triclinium’s adminstrative services.

Our central staff currently comprises four dedicated Clinical Project Managers – all with extensive experience and qualified in medical/para-medical disciplines – plus four administrative and financial support staff.

Our national network of experienced Clinical Research Associates, covers three coastal and two inland locations. All CRAs hold pharmacy, nursing, pharmacology or related science qualifications.

In addition to South Africa, we have managed clinical trials in Kenya, Uganda, Tanzania, Rwanda, Zambia and Botswana. Johannesburg has good airline links to other countries in southern and east Africa.